BE894451A - Agent antiparkinsonien - Google Patents

Agent antiparkinsonien

Info

Publication number
BE894451A
BE894451A BE0/209060A BE209060A BE894451A BE 894451 A BE894451 A BE 894451A BE 0/209060 A BE0/209060 A BE 0/209060A BE 209060 A BE209060 A BE 209060A BE 894451 A BE894451 A BE 894451A
Authority
BE
Belgium
Prior art keywords
antiparkinsonian agent
antiparkinsonian
agent
Prior art date
Application number
BE0/209060A
Other languages
English (en)
Original Assignee
Sumitomo Chemical Co
Narabayashi Hirotaro
Kondotomoyoshi
Hayashi Akira
Suzuki Tomokazo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co, Narabayashi Hirotaro, Kondotomoyoshi, Hayashi Akira, Suzuki Tomokazo filed Critical Sumitomo Chemical Co
Publication of BE894451A publication Critical patent/BE894451A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/209060A 1981-09-22 1982-09-21 Agent antiparkinsonien BE894451A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56150082A JPS5852219A (ja) 1981-09-22 1981-09-22 パ−キンソン病治療剤

Publications (1)

Publication Number Publication Date
BE894451A true BE894451A (fr) 1983-03-21

Family

ID=15489114

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/209060A BE894451A (fr) 1981-09-22 1982-09-21 Agent antiparkinsonien

Country Status (13)

Country Link
US (1) US4497826A (fr)
JP (1) JPS5852219A (fr)
AU (2) AU556542B2 (fr)
BE (1) BE894451A (fr)
CA (1) CA1184501A (fr)
CH (1) CH650926A5 (fr)
DE (1) DE3235093A1 (fr)
FR (1) FR2513117B1 (fr)
GB (1) GB2106388B (fr)
IT (1) IT1212668B (fr)
NL (1) NL189648C (fr)
NZ (1) NZ201864A (fr)
SE (1) SE462781B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575849B2 (en) * 1983-09-22 1988-08-11 Sumitomo Chemical Company, Limited Pharmaceutical composition and method for treatment of psychomotor excitement
NZ209514A (en) * 1983-09-22 1988-03-30 Sumitomo Chemical Co Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
JPS6067420A (ja) * 1983-09-22 1985-04-17 Sumitomo Chem Co Ltd 精神運動興奮抑制剤
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
JPS6185318A (ja) * 1984-10-04 1986-04-30 Sumitomo Seiyaku Kk 利尿薬
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4863962A (en) * 1988-03-02 1989-09-05 Fidia-Georgetown Institute For The Neurosciences D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
JP3559572B2 (ja) 1993-01-29 2004-09-02 住友製薬株式会社 急性痛および慢性痛用鎮痛剤
JP3764179B2 (ja) * 1994-07-05 2006-04-05 克寛 西野 運動・意識または言語障害の機能改善剤
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
GB2348371B (en) * 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US20060105036A1 (en) 2003-05-12 2006-05-18 Stephen Peroutka Threo-dops controlled release formulation
US20070010584A1 (en) * 2003-09-04 2007-01-11 Peroutka Stephen J Compositions and methods for orthostatic intolerance
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US20080015181A1 (en) * 2006-06-28 2008-01-17 Chelsea Therapeutics, Inc. Pharmaceutical Compositions Comprising Droxidopa
ES2500053T3 (es) * 2007-03-09 2014-09-29 Chelsea Therapeutics, Inc. Composición farmacéutica que comprende droxidopa para el tratamiento de la fibromialgia
EP2514417A3 (fr) * 2007-05-07 2013-01-30 Chelsea Therapeutics, Inc. Droxidopa et composition pharmaceutique à base de celle-ci pour le traitement des troubles de l'humeur, des troubles du sommeil ou des troubles déficitaires de l'attention
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
US8598370B2 (en) 2009-07-01 2013-12-03 Dainippon Sumitomo Pharma Co., Ltd. Process for producing threo-3-(3,4-dihydroxyphenyl)-L-serine
JP5880913B2 (ja) 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状（姿勢反射異常）の治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34687A (en) * 1969-06-18 1973-07-30 Merck & Co Inc Compounds of a-hydrazino-b-acid (3,4-dihydroxyphenyl) -a-converted propionate
US3658968A (en) * 1970-06-11 1972-04-25 Merck & Co Inc Composition and method of treatment
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
CH580059A5 (fr) * 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension

Also Published As

Publication number Publication date
NZ201864A (en) 1985-12-13
AU6750187A (en) 1987-04-16
SE8205404L (sv) 1983-03-23
SE8205404D0 (sv) 1982-09-21
NL8203594A (nl) 1983-04-18
CA1184501A (fr) 1985-03-26
JPH0216284B2 (fr) 1990-04-16
NL189648B (nl) 1993-01-18
GB2106388A (en) 1983-04-13
DE3235093C2 (fr) 1988-12-29
SE462781B (sv) 1990-09-03
DE3235093A1 (de) 1983-04-07
AU556542B2 (en) 1986-11-06
JPS5852219A (ja) 1983-03-28
IT1212668B (it) 1989-11-30
AU8857882A (en) 1983-03-31
FR2513117A1 (fr) 1983-03-25
NL189648C (nl) 1993-06-16
IT8268118A0 (it) 1982-09-21
GB2106388B (en) 1986-03-26
FR2513117B1 (fr) 1986-01-24
US4497826A (en) 1985-02-05
AU575267B2 (en) 1988-07-21
CH650926A5 (de) 1985-08-30

Similar Documents

Publication Publication Date Title
BE894451A (fr) Agent antiparkinsonien
BE893795A (fr) Inhalateur-doseur
AR228298A1 (es) Cubo-rompecabezas
ATA202182A (de) Geraeuschgedaempftes schienenrad
AT372860B (de) Schipaar
BE889765A (fr) Stijgerelement
NO820721L (no) Vannfritt antitranspirasjonsmiddel.
BE893877A (fr) Mond-en tandverzorgingsmiddel
FI822146A0 (fi) Kombinerad hopsamlings- och foerflyttningsanordning foer papper
FI823469L (fi) Kombinerat gas-aongprocesskraftverk
MA19539A1 (fr) N Acylaminophenylpyrazoles
BE894481A (fr) Stromingsmeter
AT384100B (de) Drehrohrofen
BE891918A (fr) Draaibare schoorsteenkap
AT379276B (de) Hoergeraet
AT385733B (de) Skibob
ATA183681A (de) Blockhaus
NO823024L (no) Fasade pussemiddel
AT374656B (de) Maishaecksler
BE893857A (fr) Comptoir-vitrine
ATA243482A (de) Mauerstein
AT386872B (de) Reibscheiben-kupplungs-bremskombination
RO81648A2 (fr) Solution medicamenteuse antiasthmatique
RO81913A2 (fr) Solution antiacneique
AT371306B (de) Hoergeraet

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SUMITOMO CHEMICAL CO.

Effective date: 20020921